{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:55:50Z","timestamp":1778806550694,"version":"3.51.4"},"reference-count":50,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.3892\/or.2013.2838","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T11:53:40Z","timestamp":1383825220000},"page":"456-462","source":"Crossref","is-referenced-by-count":26,"title":["Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein"],"prefix":"10.3892","volume":"31","author":[{"given":"YUJEONG","family":"HAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SOJUNG","family":"PARK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANN W.","family":"KINYUA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LADISLAV","family":"ANDERA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KI WOO","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"INKI","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,11,7]]},"reference":[{"key":"key20180107222915_b1-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1053\/j.gastro.2005.04.001","article-title":"Pancreatic cancer: basic and clinical aspects","volume":"128","author":"Schneider","year":"2005","journal-title":"Gastroenterology"},{"key":"key20180107222915_b2-or-31-01-0456","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2009.89","article-title":"Pancreatic cancer: molecular pathogenesis and new therapeutic targets","volume":"6","author":"Wong","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20180107222915_b3-or-31-01-0456","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1476-4598-7-64","article-title":"Apoptotic pathways in pancreatic ductal adenocarcinoma","volume":"7","author":"Hamacher","year":"2008","journal-title":"Mol Cancer"},{"key":"key20180107222915_b4-or-31-01-0456","doi-asserted-by":"crossref","first-page":"330","DOI":"10.18632\/aging.100459","article-title":"Role of apoptosis in disease","volume":"4","author":"Favaloro","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"key20180107222915_b5-or-31-01-0456","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1242\/jcs.01610","article-title":"Death receptor signaling","volume":"118","author":"Lavrik","year":"2005","journal-title":"J Cell Sci"},{"key":"key20180107222915_b6-or-31-01-0456","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.276.5309.111","article-title":"The receptor for the cytotoxic ligand TRAIL","volume":"276","author":"Pan","year":"1997","journal-title":"Science"},{"key":"key20180107222915_b7-or-31-01-0456","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0955-0674(99)80034-9","article-title":"Apoptosis control by death and decoy receptors","volume":"11","author":"Ashkenazi","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"key20180107222915_b8-or-31-01-0456","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","article-title":"Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family","volume":"271","author":"Pitti","year":"1996","journal-title":"J Biol Chem"},{"key":"key20180107222915_b9-or-31-01-0456","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/157488709787047530","article-title":"TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges","volume":"4","author":"Bellail","year":"2009","journal-title":"Rev Recent Clin Trials"},{"key":"key20180107222915_b10-or-31-01-0456","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.drup.2004.11.002","article-title":"Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy","volume":"7","author":"Van Geelen","year":"2004","journal-title":"Drug Resist Updat"},{"key":"key20180107222915_b11-or-31-01-0456","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.4161\/cbt.205","article-title":"TRAIL and anti-tumor responses","volume":"2","author":"Bhojani","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"key20180107222915_b12-or-31-01-0456","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00109-007-0194-1","article-title":"The promise of TRAIL - potential and risks of a novel anticancer therapy","volume":"85","author":"Koschny","year":"2007","journal-title":"J Mol Med (Berl)"},{"key":"key20180107222915_b13-or-31-01-0456","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.cellsig.2007.06.001","article-title":"Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells","volume":"19","author":"Wang","year":"2007","journal-title":"Cell Signal"},{"key":"key20180107222915_b14-or-31-01-0456","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1479-5876-3-22","article-title":"The anti-tumor effect of Apo2L\/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice","volume":"3","author":"Hylander","year":"2005","journal-title":"J Transl Med"},{"key":"key20180107222915_b15-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1158\/1541-7786.MCR-08-0313","article-title":"TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5","volume":"6","author":"Zhang","year":"2008","journal-title":"Mol Cancer Res"},{"key":"key20180107222915_b16-or-31-01-0456","first-page":"1688","article-title":"Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer","volume":"7","author":"Fisher","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key20180107222915_b17-or-31-01-0456","first-page":"335","article-title":"Molecular determinants of response to TRAIL in killing of normal and cancer cells","volume":"6","author":"Kim","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20180107222915_b18-or-31-01-0456","first-page":"4942","article-title":"Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers","volume":"61","author":"Shin","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107222915_b19-or-31-01-0456","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1038\/sj.onc.1207995","article-title":"Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase","volume":"23","author":"Nakshatri","year":"2004","journal-title":"Oncogene"},{"key":"key20180107222915_b20-or-31-01-0456","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.835","article-title":"Increased expression of cFLIP(L) in colonic adenocarcinoma","volume":"194","author":"Ryu","year":"2001","journal-title":"J Pathol"},{"key":"key20180107222915_b21-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.LAB.0000079328.76631.28","article-title":"Cellular FLICE\/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma","volume":"83","author":"Okano","year":"2003","journal-title":"Lab Invest"},{"key":"key20180107222915_b22-or-31-01-0456","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/sj.onc.1205258","article-title":"Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression","volume":"21","author":"Fulda","year":"2002","journal-title":"Oncogene"},{"key":"key20180107222915_b23-or-31-01-0456","first-page":"1314","article-title":"Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression","volume":"61","author":"Eggert","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107222915_b24-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/sj.leu.2402169","article-title":"The kiss of death: promises and failures of death receptors and ligands in cancer therapy","volume":"15","author":"Daniel","year":"2001","journal-title":"Leukemia"},{"key":"key20180107222915_b25-or-31-01-0456","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s10495-009-0349-3","article-title":"Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5","volume":"14","author":"Gasparian","year":"2009","journal-title":"Apoptosis"},{"key":"key20180107222915_b26-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s10529-007-9446-y","article-title":"Overexpression and refolding of thioredoxin\/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase","volume":"29","author":"Gasparian","year":"2007","journal-title":"Biotechnol Lett"},{"key":"key20180107222915_b27-or-31-01-0456","doi-asserted-by":"crossref","first-page":"20593","DOI":"10.1074\/jbc.M211010200","article-title":"Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase","volume":"278","author":"Sah","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180107222915_b28-or-31-01-0456","doi-asserted-by":"crossref","first-page":"21676","DOI":"10.1074\/jbc.M802889200","article-title":"Real time analysis of tumor necrosis factor-related apoptosis-inducing ligand\/cycloheximide-induced caspase activities during apoptosis initiation","volume":"283","author":"Hellwig","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180107222915_b29-or-31-01-0456","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat Med"},{"key":"key20180107222915_b30-or-31-01-0456","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"key20180107222915_b31-or-31-01-0456","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ctrv.2008.11.006","article-title":"TRAIL receptor signalling and modulation: are we on the right TRAIL?","volume":"35","author":"Mahalingam","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"key20180107222915_b32-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(02)00502-2","article-title":"Nature\u2019s TRAIL - on a path to cancer immunotherapy","volume":"18","author":"Smyth","year":"2003","journal-title":"Immunity"},{"key":"key20180107222915_b33-or-31-01-0456","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/bmj.1.2978.116","article-title":"The treatment of amoebic dysentery with emetine and bismuth iodide","volume":"1","author":"Lambert","year":"1918","journal-title":"Br Med J"},{"key":"key20180107222915_b34-or-31-01-0456","article-title":"Amoebic dysentery","volume":"2011","author":"Mackey-Lawrence","year":"2011","journal-title":"Clin Evid (Online)"},{"key":"key20180107222915_b35-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1073\/pnas.56.6.1867","article-title":"Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics","volume":"56","author":"Grollman","year":"1966","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107222915_b36-or-31-01-0456","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1242\/jcs.107.9.2483","article-title":"Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937","volume":"107","author":"Bicknell","year":"1994","journal-title":"J Cell Sci"},{"key":"key20180107222915_b37-or-31-01-0456","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0003-9861(02)00399-5","article-title":"Activation of the mitochondrial caspase cascade in the absence of protein synthesis does not require c-Jun N-terminal kinase","volume":"405","author":"Watanabe","year":"2002","journal-title":"Arch Biochem Biophys"},{"key":"key20180107222915_b38-or-31-01-0456","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/taap.1998.8616","article-title":"Induction of apoptosis and changes in nuclear G-actin are mediated by different pathways: the effect of inhibitors of protein and RNA synthesis in isolated rat hepatocytes","volume":"156","author":"Meijerman","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20180107222915_b39-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1055\/s-2006-941546","article-title":"Reduction of cytotoxicity of the alkaloid emetine through P-glycoprotein (MDR1\/ABCB1) in human Caco-2 cells and leukemia cell lines","volume":"72","author":"Moller","year":"2006","journal-title":"Planta Med"},{"key":"key20180107222915_b40-or-31-01-0456","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3390\/molecules13102462","article-title":"Alkaloids induce programmed cell death in bloodstream forms of trypanosomes (Trypanosoma b. brucei)","volume":"13","author":"Rosenkranz","year":"2008","journal-title":"Molecules"},{"key":"key20180107222915_b41-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.chembiol.2007.11.004","article-title":"Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism","volume":"14","author":"Boon-Unge","year":"2007","journal-title":"Chem Biol"},{"key":"key20180107222915_b42-or-31-01-0456","first-page":"737","article-title":"The alkaloid emetine as a promising agent for the induction and enhancement of drug-induced apoptosis in leukemia cells","volume":"18","author":"Moller","year":"2007","journal-title":"Oncol Rep"},{"key":"key20180107222915_b43-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3892\/ol.2011.395","article-title":"Emetine regulates the alternative splicing of caspase 9 in tumor cells","volume":"2","author":"Pan","year":"2011","journal-title":"Oncol Lett"},{"key":"key20180107222915_b44-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.cell.2005.06.009","article-title":"Mule\/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis","volume":"121","author":"Zhong","year":"2005","journal-title":"Cell"},{"key":"key20180107222915_b45-or-31-01-0456","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0360-3016(00)00803-8","article-title":"Pancreatic tumors show high levels of hypoxia","volume":"48","author":"Koong","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107222915_b46-or-31-01-0456","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2012.04.093","article-title":"Downregulation of Mcl-1 by daunorubicin pretreatment reverses resistance of breast cancer cells to TNF-related apoptosis-inducing ligand","volume":"422","author":"Oh","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107222915_b47-or-31-01-0456","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4161\/cbt.1.5.169","article-title":"Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression","volume":"1","author":"Kelly","year":"2002","journal-title":"Cancer Biol Ther"},{"key":"key20180107222915_b48-or-31-01-0456","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/cgt.2011.11","article-title":"Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells","volume":"18","author":"Kim","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"key20180107222915_b49-or-31-01-0456","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11060-004-9180-4","article-title":"In vitro effects of topotecan and ionizing radiation on TRAIL\/Apo2L-mediated apoptosis in malignant glioma","volume":"71","author":"Ciusani","year":"2005","journal-title":"J Neurooncol"},{"key":"key20180107222915_b50-or-31-01-0456","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/jcb.21729","article-title":"Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells","volume":"104","author":"Yoo","year":"2008","journal-title":"J Cell Biochem"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2838\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T19:55:06Z","timestamp":1647028506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,7]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,11,7]]},"published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.3892\/or.2013.2838"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2838","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,7]]}}}